Hepatitis E virus in the Kathmandu Valley: Insights from a representative longitudinal serosurvey
5
item.page.dc.date.issued
2024-08-01
item.page.dc.type
item.page.dc.identifier.issn
19352727
item.page.dc.identifier.eissn
19352735
item.page.dc.identifier.doi
item.page.dc.identifier.scopus
2-s2.0-85201437352
item.page.dc.identifier.pmid
39102451
item.page.oaire.citation.title
PLoS Neglected Tropical Diseases
item.page.oaire.citation.volume
18
item.page.oaire.citation.issue
8
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
PLoS Neglected Tropical Diseases Vol.18 No.8 (2024)
punsarn.item.page.citation
Katuwal N., Thapa M., Shrestha S., Vaidya K., Bogoch I.I., Shrestha R., Andrews J.R., Tamrakar D., Aiemjoy K. Hepatitis E virus in the Kathmandu Valley: Insights from a representative longitudinal serosurvey. PLoS Neglected Tropical Diseases Vol.18 No.8 (2024). doi:10.1371/journal.pntd.0012375 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/101212
item.page.dc.title
Hepatitis E virus in the Kathmandu Valley: Insights from a representative longitudinal serosurvey
item.page.dc.contributor.author
item.page.dc.contributor.correspondence
item.page.dc.contributor.other
item.page.dc.description.abstract
Background Hepatitis-E virus (HEV), an etiologic agent of acute inflammatory liver disease, is a significant cause of morbidity and mortality in South Asia. HEV is considered endemic in Nepal; but data on population-level infection transmission is sparse. Methods We conducted a longitudinal serosurvey in central Nepal to assess HEV exposure. At each visit, capillary blood samples were collected and analyzed for the presence of anti-HEV IgG antibodies. The study took place between February 2019 and April 2021, with up to 4 visits per participant approximately 6 months apart. Results We collected 2513 samples from 923 participants aged 0–25 years, finding a seroprevalence of 4.8% and a seroincidence rate of 10.9 per 1000 person-years. Young adults and individuals consuming surface water faced the highest incidence of infection. Geospatial analysis identified potential HEV clusters, suggesting a need for targeted interventions. Significance Our findings demonstrate that HEV is endemic in Nepal and that the risk of infection increases with age.
